Protocadherin Pcdh2 shows properties similar to, but distinct from, those of classical cadherins.
Cell adhesion and several other properties of a recently identified cadherin-related protein, protocadherin Pcdh2, were characterized. A chimeric Pcdh2 in which the original cytoplasmic domain was replaced with the cytoplasmic domain of E-cadherin was expressed in mouse L cells. The expressed protein had a molecular mass of about 150 kDa and was localized predominantly at the cell periphery, as was the wild-type Pcdh2. In a conventional cell aggregation assay, the transfectants showed cell aggregation activity comparable to that of classical cadherins. This activity was Ca(2+)-dependent and was inhibited by the addition of anti-Pcdh2 antibody, indicating that the chimeric Pcdh2, and probably the wild-type Pcdh2, has Ca(2+)-dependent cell aggregation activity. Mixed cell aggregation assay using L cells and different types of transfectants showed that the activity of Pcdh2 was homophilic and molecular type specific and that Pcdh2 was transfectants did not aggregate with other types of transfectants or with L cells. In immunoprecipitation, the chimeric Pcdh2 co-precipitated with a 105 kDa and a 95 kDa protein, whereas wild-type Pcdh2 co-precipitated with no major protein. Pcdh2 was easily solubilized with non-ionic detergent, in contrast to the case of classical cadherins. On immunofluorescence microscopy, the somas of Purkinje cells were diffusely stained with anti-human Pcdh2 antibody. Mouse Pcdh1 and Pcdh2 were mapped to a small segment of chromosome 18, suggesting that various protocadherins form a gene cluster at this region. The present results suggest that Pcdh2, and possibly other protocadherins as well as protocadherin-related proteins such as Drosophila fat, mediate Ca(2+)-dependent and specific homophilic cell-cell interaction in vivo and play an important role in cell adhesion, cell recognition, and/or some other basic cell processes.
Obata
S
S
Doheny Eye Institute, University of Southern California School of Medicine, Los Angeles 90033, USA.
Sago
H
H
Mori
N
N
Rochelle
J M
JM
Seldin
M F
MF
Davidson
M
M
St John
T
T
Taketani
S
S
Suzuki
S T
ST
D000818:Animals; D001483:Base Sequence; D015820:Cadherins / Q000032:analysis* / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics; D002449:Cell Aggregation; D002531:Cerebellum / Q000378:metabolism; D002874:Chromosome Mapping; D003593:Cytoplasm / Q000737:chemistry; D003598:Cytoskeletal Proteins / Q000737:chemistry; D006801:Humans; D007739:L Cells; D051379:Mice; D008969:Molecular Sequence Data; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D017434:Protein Structure, Tertiary; D000091363:Protocadherins; D011993:Recombinant Fusion Proteins / Q000032:analysis* / Q000096:biosynthesis; D051178:alpha Catenin
C495273:CTNNA1 protein, human; D015820:Cadherins; C495272:Ctnna1 protein, mouse; D003598:Cytoskeletal Proteins; D009419:Nerve Tissue Proteins; C081683:PCDH1 protein, human; C504473:Pcdh1 protein, mouse; D000091363:Protocadherins; D011993:Recombinant Fusion Proteins; D051178:alpha Catenin